Biocure Technology (XCNQ:CURE) Total Long-Term Liabilities : C$0.05 Mil (As of Dec. 2024)

View and export this data going back to 2010. Start your Free Trial

What is Biocure Technology Total Long-Term Liabilities?

Total Long-Term Liabilities includes Long-Term Debt & Capital Lease Obligation, PensionAndRetirementBenefit, NonCurrent Deferred Liabilities and Other Long-Term Liabilities. Biocure Technology's Total Long-Term Liabilities for the quarter that ended in Dec. 2024 was C$0.05 Mil.

Biocure Technology Total Long-Term Liabilities Historical Data

The historical data trend for Biocure Technology's Total Long-Term Liabilities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Biocure Technology Total Long-Term Liabilities Chart

Biocure Technology Annual Data

Trend

Mar15

Mar16

Mar17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

Total Long-Term Liabilities

Get a 7-Day Free Trial

2.92

1.25

0.04

0.05

Biocure Technology Quarterly Data
	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24
Total Long-Term Liabilities	Get a 7-Day Free Trial															0.04	0.04	0.05	0.05	0.05

Biocure Technology Total Long-Term Liabilities Calculation

Total Long-Term Liabilities represents the obiligation that incurred as part of normal operations that is expected to be repaid beyond the following twelve months or one business cycle, excluding minority interest. It includes Long-Term Debt & Capital Lease Obligation, PensionAndRetirementBenefit, NonCurrent Deferred Liabilities and Other Long-Term Liabilities.

Biocure Technology Total Long-Term Liabilities Related Terms

Thank you for viewing the detailed overview of Biocure Technology's Total Long-Term Liabilities provided by GuruFocus.com. Please click on the following links to see related term pages.

Biocure Technology Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Biocure Technology Inc (XCNQ:CURE) » Definitions » Total Long-Term Liabilities

Comparable Companies

Traded in Other Exchanges

BICTF:USA 1WH0:Germany

Address

1055 West Hastings Street, Suite 300, Vancouver, BC, CAN, V6E 2E9

Website

https://www.biocuretech.com

Biocure Technology Inc is a biopharmaceutical company specializing in the development and potential commercialization of biosimilar pharmaceutical products. It is Developing Biosimilars and CAR-T Cell pharmaceuticals. Its products are CAR-T Cell Therapy, Interferon Beta, Ranibizumab, and PEG-Filgrastim.

Executives

Konstantin Lichtenwald

Director, Senior Officer